4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-016839
Director bought 20,000 shares at an average $3.93 ($78,508)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CITRON JOEL TOMAS Director | 2006-03-06 | Purchase | +300 | $3.89 | $1,167 | 291,277 | D: show line 1 in the form |
| CITRON JOEL TOMAS Director | 2006-03-06 | Purchase | +500 | $3.90 | $1,950 | 291,777 | D: show line 2 in the form |
| CITRON JOEL TOMAS Director | 2006-03-06 | Purchase | +700 | $3.95 | $2,765 | 292,477 | D: show line 3 in the form |
| CITRON JOEL TOMAS Director | 2006-03-06 | Purchase | +100 | $3.96 | $396 | 292,577 | D: show line 4 in the form |
| CITRON JOEL TOMAS Director | 2006-03-07 | Purchase | +400 | $3.86 | $1,544 | 292,977 | D: show line 5 in the form |
| CITRON JOEL TOMAS Director | 2006-03-07 | Purchase | +100 | $3.87 | $387 | 293,077 | D: show line 6 in the form |
| CITRON JOEL TOMAS Director | 2006-03-07 | Purchase | +200 | $3.88 | $776 | 293,277 | D: show line 7 in the form |
| CITRON JOEL TOMAS Director | 2006-03-07 | Purchase | +2,700 | $3.89 | $10,503 | 295,977 | D: show line 8 in the form |
| Open-market purchases · 20,000 sh · avg $3.93 · $78,508 | |||||||
Loading xslF345X02/rrd110628.xml…